if (have_posts()) : while (have_posts()) : the_post(); ?>
Pricing and Market Access Strategy for a Haematology Product in the GCC

Value & Access

Pricing and Market Access Strategy for a Haematology Product in the GCC

Project Scope

To understand price potential for a sickle cell disease product in GCC markets

KSA

KSA

Oman

Oman

UAE

UAE

Bahrain

Bahrain

Kuwait

Kuwait

Qatar

Qatar

Challenge

Our client has a sickle disease portfolio and wanted to understand how to optimally launch in GCC markets through understanding the price potential and feasibility of innovative contracting in order to boost patient access

Solution

  • In-depth secondary research was conducted focusing on understanding the prevalence of SCD, patient journey and competitor products
  • Conducted primary research consisting of qualitative and quantitative discussions to understand the nuances within the SCD landscape across key geographies
  • Tested the price and access potential of the novel therapeutic agent

Results

  • Successfully enabled our client to develop a localised list and net price strategies per market
  • Recommended optimal regional launch sequence to manage international price referencing risks

Note: GCC: Gulf Cooperation Council, SCD: Sickle Cell Disease